Clinical Pharmacology Branch, Clinical Oncology Program, and Laboratory of Medicinal Chemistry and Biology, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20205, USA.
Biochem Pharmacol. 1980 Mar 1;29(5):807-11. doi: 10.1016/0006-2952(80)90561-4.
Cytidine deaminase, an enzyme found in the supernatant fluid of hepatocytes, granulocytes and tumor cells, and in plasma, degrades the antitumor agents cytosine arabinoside and 5-azacytidine. Uridine and its analogs, 3-deazauridine, 5-bromodeoxyuridine, 5-fluorodeoxyuridine and 6-azauridine, were found to competitively inhibit cytidine deaminase; the most potent inhibitor was 3-deazauridine (K(i) = 1.9 x 10(-5) M). In addition, deoxycytidylate deaminase, which degrades cytosine arabinoside monophosphate to the inactive uracil arabinoside monophosphate (K(m) = 9 x 10(-4) M), was competitively inhibited by 3-deazauridine monophosphate, as well as by the nucleotides of other uridine analogs. These results suggest that uridine analogs such as 3-deazauridine may have value in protecting cytosine arabinoside, 5-azacytidine and their monophosphate nucleotides from degration by neucleoside and nucleotide deaminases.
胞苷脱氨酶是一种存在于肝细胞、粒细胞和肿瘤细胞上清液以及血浆中的酶,可降解抗肿瘤药物阿糖胞苷和 5-氮杂胞苷。尿嘧啶及其类似物,如 3-脱氮尿苷、5-溴脱氧尿苷、5-氟脱氧尿苷和 6-氮杂尿苷,被发现竞争性抑制胞苷脱氨酶;最有效的抑制剂是 3-脱氮尿苷(K(i) = 1.9 x 10(-5) M)。此外,脱氧胞苷脱氨酶将阿糖胞苷单磷酸降解为无活性的尿嘧啶阿拉伯糖苷单磷酸(K(m) = 9 x 10(-4) M),也被 3-脱氮尿苷单磷酸以及其他尿嘧啶类似物的核苷酸竞争性抑制。这些结果表明,像 3-脱氮尿苷这样的尿嘧啶类似物可能具有保护阿糖胞苷、5-氮杂胞苷及其单磷酸核苷酸免受核苷酸和核苷脱氨酶降解的价值。